Grants and Contributions:

Back to search

Title:

Minimally Invasive Bleb-Forming Punch

Agreement Number:

997106

Agreement Value:

$75,000.00

Agreement Date:

Nov 7, 2022 - Feb 29, 2024

Description:

Presenting early-stage glaucoma patients with a minimally invasive approach to lower intraocular pressure with a bleb-forming procedure as an alternative to traditional trabeculectomy or tube surgery. Minimally Invasive Bleb-Forming Punch (MIBP) uses a new, creative injector punch to drain the liquid out of the eye. The punch removes tissue creating a tunnel to allow the eye to drain without the need for an implant. This next generation glaucoma surgery is targeted to early-stage patients as an outpatient procedure. Although the MIBS devices depend on creating an external filtering bleb, they are associated with fewer risks than traditional glaucoma surgeries, offering a favorable safety profile procedure with faster recovery.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Dieppe, New Brunswick, CA E1A 7R8

Reference Number:

172-2022-2023-Q3-997106

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

766125470

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.

Amendment Date

Dec 14, 2023

Recipient's Legal Name:

Hexiris Inc.

Federal Riding Name:

Beauséjour

Federal Riding Number:

13002

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

339110

Amendments:

See Amendments